Shaffer, M. | Search bioRxiv

bioRxiv2018

AMON: Annotation of metabolite origins via networks to better integrate microbiome and metabolome data

MotivationUntargeted metabolomics of host-associated samples has yielded insights into mechanisms by which microbes modulate health. However, data interpretation is challenged by the complexity of origins of the small molecules measured, which can come from the host, microbes that live with the host, or from other exposures such as diet or the environment.\n\nResultsWe address this challenge through development of AMON: Annotation of Metabolite Origins via Networks. AMON is an open-source bioinformatics application that can be used to determine the degree to which annotated compounds in the metabolome may have been produced by bacteria present, the host, either (i.e. both the bacteria and host are capable of production), or neither (i.e. neither the human or the fecal microbiome are predicted to be capable of producing the observed metabolite).\n\nAvailability and ImplementationThis software is available at https://github.com/lozuponelab/AMON as well as via pip.\n\nContactcatherine.lozupone@ucdenver.edu

bioinformatics↗

bioRxiv2018

An exploration of Prevotella-rich microbiomes in HIV and men who have sex with men

BackgroundGut microbiome characteristics associated with HIV infection are of intense research interest but a deep understanding has been challenged by confounding factors across studied populations. Notably, a Prevotella-rich microbiome described in HIV-infected populations is now understood to be common in men who have sex with men (MSM) regardless of HIV status, but driving factors and potential health implications are unknown.\n\nResultsHere we further define the MSM-associated gut microbiome and describe compositional differences between the fecal microbiomes of Prevotella-rich MSM and non-MSM that may underlie observed pro-inflammatory properties. Furthermore, we show relatively subtle gut microbiome changes in HIV infection in MSM and women that include an increase in potential pathogens that is ameliorated with antiretroviral therapy (ART). Lastly, using a longitudinal cohort, we describe microbiome changes that happen after ART initiation.\n\nConclusionsThis study provides an in-depth characterization of microbiome differences that occur in a US population infected with HIV and demonstrates the degree to which these differences may be driven by lifestyle factors, ART and HIV infection itself. Understanding microbiome compositions that occur with sexual behaviors that are high-risk for acquiring HIV and untreated and ART-treated HIV infection will guide the investigation of immune and metabolic functional implications to ultimately target the microbiome therapeutically.

microbiology↗